The Role of «Novel» Biomarkers of Systemic Inflammation in the Development of Early Hospital Events after Aortic Valve Replacement in Patients with Aortic Stenosis
Introduction. The pathogenesis of aortic stenosis includes the processes of chronic inflammation, calcification, lipid metabolism disorders, and congenital structural changes. The goal of our study was to determine the predictive value of novel biomarkers of systemic inflammation and some hematologi...
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2023-06-01
|
| Series: | Life |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2075-1729/13/6/1395 |
| _version_ | 1797593770971103232 |
|---|---|
| author | Vladimir Shvartz Maria Sokolskaya Artak Ispiryan Madina Basieva Polina Kazanova Elena Shvartz Sayali Talibova Andrey Petrosyan Teymuraz Kanametov Sergey Donakanyan Leo Bockeria Elena Golukhova |
| author_facet | Vladimir Shvartz Maria Sokolskaya Artak Ispiryan Madina Basieva Polina Kazanova Elena Shvartz Sayali Talibova Andrey Petrosyan Teymuraz Kanametov Sergey Donakanyan Leo Bockeria Elena Golukhova |
| author_sort | Vladimir Shvartz |
| collection | DOAJ |
| description | Introduction. The pathogenesis of aortic stenosis includes the processes of chronic inflammation, calcification, lipid metabolism disorders, and congenital structural changes. The goal of our study was to determine the predictive value of novel biomarkers of systemic inflammation and some hematological indices based on the numbers of leukocytes and their subtypes in the development of early hospital medical conditions after mechanical aortic valve replacement in patients with aortic stenosis. Materials and methods. This was a cohort study involving 363 patients who underwent surgical intervention for aortic valve pathology between 2014 and 2020. The following markers of systemic inflammation and hematological indices were studied: SIRI (Systemic Inflammation Response Index), SII (Systemic Inflammation Index), AISI (Aggregate Index of Systemic Inflammation), NLR (Neutrophil/Lymphocyte Ratio), PLR (Platelet/Lymphocyte Ratio), and MLR (Monocyte/Lymphocyte Ratio). Associations of the levels of these biomarkers and indices with the development of in-hospital death, acute kidney injury, postoperative atrial fibrillation, stroke/acute cerebrovascular accident, and bleeding were calculated. Results. According to an ROC analysis, an SIRI > 1.5 (<i>p</i> < 0.001), an SII > 718 (<i>p</i> = 0.002), an AISI > 593 (<i>p</i> < 0.001), an NLR > 2.48 (<i>p</i> < 0.001), a PLR > 132 (<i>p</i> = 0.004), and an MLR > 0.332 (<i>p</i> < 0.001) were statistically significantly associated with in-hospital death. Additionally, an SIRI > 1.5 (<i>p</i> < 0.001), an NLR > 2.8 (<i>p</i> < 0.001), and an MLR > 0.392 (<i>p</i> < 0.001) were associated with bleeding in the postoperative period. In a univariate logistic regression, SIRI, SII, AISI, and NLR were statistically significant independent factors associated with in-hospital death. In a multivariate logistic regression model, SIRI was the most powerful marker of systemic inflammation. Conclusion. SIRI, SII, AISI, and NLR as novel biomarkers of systemic inflammation were associated with in-hospital mortality. Of all markers and indices of systemic inflammation in our study, SIRI was the strongest predictor of a poor outcome in the multivariate regression model. |
| first_indexed | 2024-03-11T02:14:12Z |
| format | Article |
| id | doaj.art-29b23596e62042999a3d52a0acf45306 |
| institution | Directory Open Access Journal |
| issn | 2075-1729 |
| language | English |
| last_indexed | 2024-03-11T02:14:12Z |
| publishDate | 2023-06-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Life |
| spelling | doaj.art-29b23596e62042999a3d52a0acf453062023-11-18T11:18:41ZengMDPI AGLife2075-17292023-06-01136139510.3390/life13061395The Role of «Novel» Biomarkers of Systemic Inflammation in the Development of Early Hospital Events after Aortic Valve Replacement in Patients with Aortic StenosisVladimir Shvartz0Maria Sokolskaya1Artak Ispiryan2Madina Basieva3Polina Kazanova4Elena Shvartz5Sayali Talibova6Andrey Petrosyan7Teymuraz Kanametov8Sergey Donakanyan9Leo Bockeria10Elena Golukhova11Bakulev National Medical Research Center for Cardiovascular Surgery, Moscow 121552, RussiaBakulev National Medical Research Center for Cardiovascular Surgery, Moscow 121552, RussiaBakulev National Medical Research Center for Cardiovascular Surgery, Moscow 121552, RussiaBakulev National Medical Research Center for Cardiovascular Surgery, Moscow 121552, RussiaBakulev National Medical Research Center for Cardiovascular Surgery, Moscow 121552, RussiaNational Medical Research Center for Therapy and Preventive Medicine, Moscow 101990, RussiaBakulev National Medical Research Center for Cardiovascular Surgery, Moscow 121552, RussiaBakulev National Medical Research Center for Cardiovascular Surgery, Moscow 121552, RussiaBakulev National Medical Research Center for Cardiovascular Surgery, Moscow 121552, RussiaBakulev National Medical Research Center for Cardiovascular Surgery, Moscow 121552, RussiaBakulev National Medical Research Center for Cardiovascular Surgery, Moscow 121552, RussiaBakulev National Medical Research Center for Cardiovascular Surgery, Moscow 121552, RussiaIntroduction. The pathogenesis of aortic stenosis includes the processes of chronic inflammation, calcification, lipid metabolism disorders, and congenital structural changes. The goal of our study was to determine the predictive value of novel biomarkers of systemic inflammation and some hematological indices based on the numbers of leukocytes and their subtypes in the development of early hospital medical conditions after mechanical aortic valve replacement in patients with aortic stenosis. Materials and methods. This was a cohort study involving 363 patients who underwent surgical intervention for aortic valve pathology between 2014 and 2020. The following markers of systemic inflammation and hematological indices were studied: SIRI (Systemic Inflammation Response Index), SII (Systemic Inflammation Index), AISI (Aggregate Index of Systemic Inflammation), NLR (Neutrophil/Lymphocyte Ratio), PLR (Platelet/Lymphocyte Ratio), and MLR (Monocyte/Lymphocyte Ratio). Associations of the levels of these biomarkers and indices with the development of in-hospital death, acute kidney injury, postoperative atrial fibrillation, stroke/acute cerebrovascular accident, and bleeding were calculated. Results. According to an ROC analysis, an SIRI > 1.5 (<i>p</i> < 0.001), an SII > 718 (<i>p</i> = 0.002), an AISI > 593 (<i>p</i> < 0.001), an NLR > 2.48 (<i>p</i> < 0.001), a PLR > 132 (<i>p</i> = 0.004), and an MLR > 0.332 (<i>p</i> < 0.001) were statistically significantly associated with in-hospital death. Additionally, an SIRI > 1.5 (<i>p</i> < 0.001), an NLR > 2.8 (<i>p</i> < 0.001), and an MLR > 0.392 (<i>p</i> < 0.001) were associated with bleeding in the postoperative period. In a univariate logistic regression, SIRI, SII, AISI, and NLR were statistically significant independent factors associated with in-hospital death. In a multivariate logistic regression model, SIRI was the most powerful marker of systemic inflammation. Conclusion. SIRI, SII, AISI, and NLR as novel biomarkers of systemic inflammation were associated with in-hospital mortality. Of all markers and indices of systemic inflammation in our study, SIRI was the strongest predictor of a poor outcome in the multivariate regression model.https://www.mdpi.com/2075-1729/13/6/1395aortic stenosissystemic inflammation response indexsystemic inflammation indexaggregate inflammation systemic indexneutrophil/lymphocyte ratioplatelet/lymphocyte ratio |
| spellingShingle | Vladimir Shvartz Maria Sokolskaya Artak Ispiryan Madina Basieva Polina Kazanova Elena Shvartz Sayali Talibova Andrey Petrosyan Teymuraz Kanametov Sergey Donakanyan Leo Bockeria Elena Golukhova The Role of «Novel» Biomarkers of Systemic Inflammation in the Development of Early Hospital Events after Aortic Valve Replacement in Patients with Aortic Stenosis Life aortic stenosis systemic inflammation response index systemic inflammation index aggregate inflammation systemic index neutrophil/lymphocyte ratio platelet/lymphocyte ratio |
| title | The Role of «Novel» Biomarkers of Systemic Inflammation in the Development of Early Hospital Events after Aortic Valve Replacement in Patients with Aortic Stenosis |
| title_full | The Role of «Novel» Biomarkers of Systemic Inflammation in the Development of Early Hospital Events after Aortic Valve Replacement in Patients with Aortic Stenosis |
| title_fullStr | The Role of «Novel» Biomarkers of Systemic Inflammation in the Development of Early Hospital Events after Aortic Valve Replacement in Patients with Aortic Stenosis |
| title_full_unstemmed | The Role of «Novel» Biomarkers of Systemic Inflammation in the Development of Early Hospital Events after Aortic Valve Replacement in Patients with Aortic Stenosis |
| title_short | The Role of «Novel» Biomarkers of Systemic Inflammation in the Development of Early Hospital Events after Aortic Valve Replacement in Patients with Aortic Stenosis |
| title_sort | role of novel biomarkers of systemic inflammation in the development of early hospital events after aortic valve replacement in patients with aortic stenosis |
| topic | aortic stenosis systemic inflammation response index systemic inflammation index aggregate inflammation systemic index neutrophil/lymphocyte ratio platelet/lymphocyte ratio |
| url | https://www.mdpi.com/2075-1729/13/6/1395 |
| work_keys_str_mv | AT vladimirshvartz theroleofnovelbiomarkersofsystemicinflammationinthedevelopmentofearlyhospitaleventsafteraorticvalvereplacementinpatientswithaorticstenosis AT mariasokolskaya theroleofnovelbiomarkersofsystemicinflammationinthedevelopmentofearlyhospitaleventsafteraorticvalvereplacementinpatientswithaorticstenosis AT artakispiryan theroleofnovelbiomarkersofsystemicinflammationinthedevelopmentofearlyhospitaleventsafteraorticvalvereplacementinpatientswithaorticstenosis AT madinabasieva theroleofnovelbiomarkersofsystemicinflammationinthedevelopmentofearlyhospitaleventsafteraorticvalvereplacementinpatientswithaorticstenosis AT polinakazanova theroleofnovelbiomarkersofsystemicinflammationinthedevelopmentofearlyhospitaleventsafteraorticvalvereplacementinpatientswithaorticstenosis AT elenashvartz theroleofnovelbiomarkersofsystemicinflammationinthedevelopmentofearlyhospitaleventsafteraorticvalvereplacementinpatientswithaorticstenosis AT sayalitalibova theroleofnovelbiomarkersofsystemicinflammationinthedevelopmentofearlyhospitaleventsafteraorticvalvereplacementinpatientswithaorticstenosis AT andreypetrosyan theroleofnovelbiomarkersofsystemicinflammationinthedevelopmentofearlyhospitaleventsafteraorticvalvereplacementinpatientswithaorticstenosis AT teymurazkanametov theroleofnovelbiomarkersofsystemicinflammationinthedevelopmentofearlyhospitaleventsafteraorticvalvereplacementinpatientswithaorticstenosis AT sergeydonakanyan theroleofnovelbiomarkersofsystemicinflammationinthedevelopmentofearlyhospitaleventsafteraorticvalvereplacementinpatientswithaorticstenosis AT leobockeria theroleofnovelbiomarkersofsystemicinflammationinthedevelopmentofearlyhospitaleventsafteraorticvalvereplacementinpatientswithaorticstenosis AT elenagolukhova theroleofnovelbiomarkersofsystemicinflammationinthedevelopmentofearlyhospitaleventsafteraorticvalvereplacementinpatientswithaorticstenosis AT vladimirshvartz roleofnovelbiomarkersofsystemicinflammationinthedevelopmentofearlyhospitaleventsafteraorticvalvereplacementinpatientswithaorticstenosis AT mariasokolskaya roleofnovelbiomarkersofsystemicinflammationinthedevelopmentofearlyhospitaleventsafteraorticvalvereplacementinpatientswithaorticstenosis AT artakispiryan roleofnovelbiomarkersofsystemicinflammationinthedevelopmentofearlyhospitaleventsafteraorticvalvereplacementinpatientswithaorticstenosis AT madinabasieva roleofnovelbiomarkersofsystemicinflammationinthedevelopmentofearlyhospitaleventsafteraorticvalvereplacementinpatientswithaorticstenosis AT polinakazanova roleofnovelbiomarkersofsystemicinflammationinthedevelopmentofearlyhospitaleventsafteraorticvalvereplacementinpatientswithaorticstenosis AT elenashvartz roleofnovelbiomarkersofsystemicinflammationinthedevelopmentofearlyhospitaleventsafteraorticvalvereplacementinpatientswithaorticstenosis AT sayalitalibova roleofnovelbiomarkersofsystemicinflammationinthedevelopmentofearlyhospitaleventsafteraorticvalvereplacementinpatientswithaorticstenosis AT andreypetrosyan roleofnovelbiomarkersofsystemicinflammationinthedevelopmentofearlyhospitaleventsafteraorticvalvereplacementinpatientswithaorticstenosis AT teymurazkanametov roleofnovelbiomarkersofsystemicinflammationinthedevelopmentofearlyhospitaleventsafteraorticvalvereplacementinpatientswithaorticstenosis AT sergeydonakanyan roleofnovelbiomarkersofsystemicinflammationinthedevelopmentofearlyhospitaleventsafteraorticvalvereplacementinpatientswithaorticstenosis AT leobockeria roleofnovelbiomarkersofsystemicinflammationinthedevelopmentofearlyhospitaleventsafteraorticvalvereplacementinpatientswithaorticstenosis AT elenagolukhova roleofnovelbiomarkersofsystemicinflammationinthedevelopmentofearlyhospitaleventsafteraorticvalvereplacementinpatientswithaorticstenosis |